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Abstract
Background: Traditionally a 1-cm margin has been accepted as the gold standard for resection of
colorectal liver metastases. Evidence is emerging that a lesser margin may provide equally acceptable
outcomes, but a critical margin, below which recurrence is higher and survival poorer, has not been
universally agreed. In a recent publication, we reported peri-operative morbidity and clear margin as the
two independent prognostic factors. The aim of the current study was to further analyse the effect of the
width of the surgical margin on patient survival to determine whether a margin of 1 mm is adequate.
Methods: Two hundred and sixty-one consecutive primary liver resections for colorectal metastases
were analysed from 1992 to 2007. The resection margins were assessed by microscopic examination of
paraffin sections. The initial analysis was performed on five groups according to the resection margins:
involved margin, 0–1 mm, >1–<4 mm, 4–<10 mm and  10 mm. Subsequent analysis was based on two
groups: margin <1 mm and >1 mm.
Results: With a median follow-up of 4.7 years, the overall 5-year patient and disease-free survival were
38% and 22%, respectively. There was no significant difference in patient- or disease-free survival
between the three groups with resection margins >1 mm. When a comparison was made between
patients with resection margins 1 mm and patients with resection margins >1 mm, there was a signifi-
cant 5-year patient survival difference of 25% versus 43% (P < 0.04). However, the disease-free survival
difference did not reach statistical significance (P = 0.14).
Conclusions: In this cohort of patients, we have demonstrated that a resection margin of greater than
1 mm is associated with significantly improved 5-year overall survival, compared with involved margins or
margins less than or equal to 1 mm. The possible beneficial effect of greater margins beyond 1 mm could
not be demonstrated.
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Introduction
Colorectal cancer is one of the most common malignant tumours
accounting for at least 1 million new cases worldwide each year.1
Haematogenous spread to the liver occurs in 40–60% of these
patients.2 Hepatic resection is still the only potentially curative
therapeutic option in patients with colorectal liver metastases.3–5
Surgical resection margin status is one of the factors that has
been evaluated for its influence on long-term survival. Most
authors have reported that resection margin involvement is a sig-
nificant, and consistently the most important factor influencing
overall patient- and disease-free survival. For decades, the
accepted gold standard was the ‘1-cm rule’, which stated that resec-
tion for colorectal liver metastases should only be performed if a
margin of 10 mm or more could be achieved.6,7
However, recent studies have indicated that margins of less than
1 cm are not a contraindication to resection of colorectal liver
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metastasis; and in fact have a favourable outcome. This implies
that patients, in whom only a sub-centimetre resection margin is
possible, should not be precluded from undergoing resection.8,9
We had previously reported our experience with prognostic
factors after resection of colorectal liver metastases.10 Peri-
operative morbidity and a clear margin were the only independent
prognostic factors in the multivariate analysis. We defined a clear
margin as 1 mm or greater and in this study aimed to validate the
selection of 1 mm as the appropriate cut off margin.
Material and methods
Patients, data collection and surgical therapy
All patients who underwent liver resection for colorectal metasta-
sis with curative intent were included in the study (staged resec-
tions and re-do resections were excluded from the study). The
total number of patients included in this study was 261. The
operations were performed between February 1992 and Decem-
ber 2007 at Flinders Medical Centre, Ashford Community Hospi-
tal and The Queen Elizabeth Hospital in Adelaide, South
Australia, Australia.
Data about the operation, type of resection and complications
were recorded prospectively by the responsible surgeons (R.T.A.P.,
J.W.C.C. and G.J.M.). Data on resection margins, number of
lesions, stage and location of the primary tumour, time between
the bowel resection and liver surgery, and recurrence were
obtained from a database. Mortality was confirmed with the
South Australian cancer registry.
Patients were staged preoperatively using computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) of the abdomen,
as well as chest X-rays or CT chest. In the latter component of the
series, selected cases underwent positron emission tomography
(PET) scanning to rule out extra-hepatic disease. Colonoscopies
were also performed where appropriate as part of staging.
All patients underwent exploratory laparotomy and intra-
operative evaluation using ultrasound to confirm intra-hepatic
lesions. The types of resections were classified as wedge resection,
segmentectomy, sectionectomy, hemi-hepatectomy or extended
hemi-hepatectomy. The resections were performed or supervised
by three hepato-pancreatico-biliary surgeons (R.T.A.P., J.W.C.C.,
G.J.M.). The operations were performed using a combination of
clip dissection, cavitron ultrasonic aspirator, argon plasma coagu-
lation and ultrasonic shears. The Pringle manoeuvre was applied
at the discretion of the operating surgeon. Fourteen patients
underwent synchronous colorectal and liver resections.
Histopathological analysis
The resection margins were measured by microscopic examina-
tion of paraffin sections by a pathologist. The resections were
defined as microscopically involved (R1 resection) by the presence
of tumour cells at the line of transection detected by histological
examination. In specimens with uninvolved resection margins
(R0 resection), the distance from the tumour to the closest resec-
tion margin was measured in millimetres. The specimens in which
no measurements were recorded in the original pathology report,
were re-reviewed by a single pathologist and the margins
measured.
Statistics
Overall survival and disease-free survival rates were analysed
using Kaplan–Meier survival statistics. All patients were included
in the analysis (including the patients who died within 30 days
post-operatively or in hospital). Statistical analyses were carried
out using Stata Statistical Software: Release 10 (StataCorp. 2007).
Results
Demographics
The clinical features of the patients included in this study are
presented in Table 1. Two hundred and sixty-one patients were
included in the study, 163 (62.5%) were male and 98 (37.5%)
female. Median age was 64 years (range 21.7 to 92.0 years). Eighty-
two (31.4%) were older than 70 years, 148 (56.7%) between 50
and 70 years and 31 (11.9%) were younger than 50 years of age.
The primary colorectal carcinoma (CRC) was located in the
colon in 158 patients and in the rectum in 103 patients. Eleven
patients had CRC stage Dukes’ A (4%), 70 were Dukes’ B (27%),
110 were Dukes’ C (42%) and 70 patients had synchronous liver
metastases (27%).
Table 1 Clinical features of patients (n = 261)
Patient factors No. of patients (%)
Age
Median 64 years
>70 years 82 (31.4)
50–70 years 148 (56.7)
<50 years 31 (11.9)
Gender
Female 98 (37.5)
Male 163 (62.5)
Site of primary CRC
Colon 158 (60.5)
Rectum 103 (39.5)
Dukes staging
A 11 (4)
B 70 (27)
C 110 (42)
Synchronous liver metastases 70 (27)
Type of hepatic resection
Wedge resection/segmentectomy 51 (19.5)
2 segmentectomies 52 (20)
Hemi-hepatectomy 101 (39)
Extended hemi-hepatectomy 57 (21.5)
CRC, colorectal carcinoma.
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Operative details
Fifty-one (19.5%) patients were treated with wedge resection or
segmentectomy. Fifty-two (20%) patients underwent at least two
segmentectomies. One hundred and one (39%) were subjected to
a hemi-hepatectomy and 57 (21.5%) were treated with at least an
extended hemi-hepatectomy. Fourteen patients underwent syn-
chronous colorectal and hepatic resections. One patient under-
went a hepatic resection prior to a colorectal resection.
Two hundred and forty-six patients were first treated with a
colonic or rectal resection followed by hepatic resection, with a
mean time between first and second operations of 19.1 months
(range 1.2 to 144.8 months). Of these patients, 118 (48%) patients
underwent hepatic resection within a year after their colorectal
resection. The post-operative mortality rate (in-hospital and
30-day post-operative) was 1.9% (5 out of 261 patients).
Resection margins and survival
The overall 1-, 3- and 5-year patient survival for this cohort was
88.1%, 61.4% and 37.9%, respectively, with a median patient sur-
vival of 46.7 months. The 1-, 3- and 5-year disease-free survival
for this group was 58.5%, 32.5% and 22.4%, respectively, with
a median disease-free survival of 17.5 months. The median
follow-up was 4.7 years (range 0.3 to 192 months).
In our study, we first divided all patients into five categories
according to their resection margins; microscopically involved or
R1 resection (n = 28), uninvolved resection margins up to 1 mm
(n = 39), more than 1 mm to less than 4 mm (n = 44), 4 mm to less
than 10 mm (n = 63), 10 mm or more (n = 87).
The 1-, 3- and 5-year patient survival data for the separate
groups are tabulated in Table 2. In this analysis, there were statis-
tically significant differences between the group with involved
margin and the group with margins  10 mm only (P < 0.03).
In order to compare our results with other studies, we per-
formed a second analysis where the patients were divided into
three groups according to their resection margins; margin
involved and up to 1 mm (n = 67), margin > 1 mm to less than
10 mm (n = 107), and margin at least 10 mm (n = 87).
The disease-free survival and overall survival analyses of these
three groups are shown in Tables 3 and 4. The results show a
statistically significant difference between the first and third
Table 2 Resection margins and survival
Resection margin n Patient survival P
Median
(months)
1 year 3 years 5 years
Involved 28 25.8 81% 45% 19% reference
0–1 mm 39 45.4 79% 63% 29% ns
>1–<4 mm 44 54.5 91% 71% 47% ns
4–<10 mm 63 51.7 86% 56% 38% ns
10 mm 87 54.7 95% 65% 44% <0.03
Overall 261 46.7 88% 61% 38%
Table 3 Analysis of impact of margin on disease-free survival
Resection margin n Disease free survival P
Median
(months)
1 year 3 years 5 years
Involved – 1 mm 67 10.1 41% 21% 17% reference
>1 mm to <10 mm 107 16.8 58% 28% 20% 0.15
10 mm 87 24.1 64% 41% 29% <0.02
Overall 261 17.5 58% 33% 22%
Table 4 Analysis of impact of margin on overall survival
Resection margin n Patient survival P
Median
(months)
1 year 3 years 5 years
Involved – 1 mm 67 39 81% 45% 19% reference
>1 mm to <10 mm 107 52 85% 63% 38% 0.081
10 mm 87 54 95% 65% 43% <0.03
Overall 261 46 88% 61% 38%
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groups in overall survival as well as in disease-free survival.
However, there was no significant survival difference between the
first and second, or the second and third groups.
Further analyses where performed to ascertain the minimum
resection margin that was significant in terms of overall survival
and disease-free survival. The resection margins were sequentially
analysed until statistical significance was reached. We found that a
1-mm margin was the statistically significant cut-off point.
Comparing patients with resection margins 1 mm and resec-
tion margins > 1 mm, there was a statistically significant differ-
ence in overall survival (P = 0.04). However, no significant
difference in disease-free survival was found (P = 0.14).
(Tables 5,6, Fig. 1).
Discussion
A number of variables have been described as prognostic factors
in hepatic resection for colorectal metastasis to the liver, including
nodal status of the primary tumour, disease-free interval,
carcinoembryonic antigen (CEA) level, number and distribution
of metastatic lesions, size of largest tumour and extent of
resection.3–5,7 It is generally accepted that the surgical resection
margin is a significant prognostic factor, however, there is cur-
rently no clear-cut consensus regarding the accepted minimum
margin of clearance associated with favourable survival and
disease-free outcomes. Since the 1980s, there has been a general
consensus that a 10 mm or more tumour-free resection margin is
required, and if it is not possible then resection should not be
attempted. However, recent studies suggest that similar outcomes
can be obtained with sub-centimetre resection margins.7–9,11
It is essential to note the importance of avoiding an incom-
plete resection when performing a hepatic resection for colorec-
tal metastasis. It is our routine practice to utilize radiological
investigations including CT scans and MRI scans of the liver
pre-operatively. In addition, intra-operative ultrasound is an
essential tool during these operations.12 Most surgeons would
agree that the resection margin of the post-operative specimen is
always narrower than suggested on the pre-operative imaging
studies. Elias et al.13 investigated the amount of liver lost during
hemi-hepatectomies using the clamp transection technique and
indicated that between 5 and 8 mm of tumour-free margin will
be lost during a hemi-hepatectomy because of this surgical
technique, compared with the pre-operative measurements
on imaging. We do not know the width of parenchyma lost
during Cavitron ultrasonic surgical aspirator (CUSA)
dissection.
There have been several recent publications evaluating out-
comes in relation to liver resection margins. Table 7 summarizes
the outcomes from studies which have been noted to have signifi-
cant patient numbers. Earlier studies by Wray et al.14 and Cady
et al.15 demonstrated the need for 10-mm resection margins in
order to obtain significant survival benefits and low recurrence
rates. In fact, Wray et al. recommended that a formal anatomical
resection may confer an oncological benefit compared with a
limited resection. Current trends for the approach to hepatic
resections for colorectal metastases are more aggressive, and our
data would support that of others that a significant survival
benefit is obtained with a smaller margin.
The study published by the Memorial Sloan Kettering group9
was impressively large, but could only prove that a margin greater
than 10 mm is an independent predictor of survival after hepatic
resection for colorectal metastases. However, the authors did note
that sub-centimetre resections are associated with favourable out-
comes when compared with other modalities of treatment, and
therefore recommended that the inability to achieve a 10-mm
resection margin should not preclude the patient from undergo-
ing a hepatic resection. The authors also indicated that their exclu-
sive use of the Kelly clamp crush technique may have created a
margin of different character than other techniques.
In contrast to the above studies, Bodingbauer et al.16 described
recurrence-free survival as well as overall survival curves that were
not influenced by the pathological margin status in their study of
Table 5 Comparison of impact of resection margins  1 mm and
>1 mm on overall survival
Resection margin n Patient survival P
3 years 5 years
1 mm 67 55% 25% reference
>1 mm 194 63.7% 42.7% 0.04
Table 6 Comparison of impact of resection margins 1 mm and
>1 mm on disease-free survival
Resection margin n Disease-free survival P
3 years 5 years
1 mm 67 27.5% 18.6% reference
>1 mm 194 35% 23.6% 0.14
Resection margins 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 1 2 3 4 5 6
Patient survival (years)
Involved - 1mm
>1mm
Figure 1 Graph of overall survival according to resection margin
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176 patients. This conclusion was supported by de Haas et al.17
who looked at R0 compared with R1 resection margins of colorec-
tal liver metastases and found no significant difference in 5-year
overall survival or disease-free recurrence between these two
groups. However, this study did not define the exact nature of an
R1 resection margin, nor did it quantify the exact margins widths
for R0 resections.
In our study, a resection margin of 10 mm or greater was
achieved in 33.3% (87 out of 261) of resected specimens. This is
comparable to other reported series with rates between 33% and
40%.9,16 The initial conclusions of significant overall survival and
disease-free survival were drawn from data comparing involved
resection margins with margins of at least 10 mm. Further analy-
ses found that a resection margin of greater than 1 mm is associ-
ated with a favourable outcome and good long-term survival. The
possible beneficial effect of greater margins beyond 1 mm could
not be clearly demonstrated. The results of our study are consis-
tent with those reported by the MD Anderson study.8 It is worth
noting that in this study, the authors defined a positive margin as
the presence of tumour cells at the line of transection or a margin
less than 1 mm.
It is possible that a margin of less than 1 mm with at least some
hepatic parenchyma may be adequate. We could not definitely
determine this in our study. While the survival with a lesser
margin is inferior, worthwhile 5-year survivals are still reported, in
concordance with our study. Our results show that patients who
had involved margins had a 5-year survival of 19%; still a much
better outcome when compared with chemotherapy alone as
initial treatment. Four out of the 28 patients with involved resec-
tion margins were R2 resections; however, it is likely that a pos-
sible margin had been achieved using our transection technique.
We also found no significant difference in the rate of resection
margins  1 mm between patients who underwent anatomical
liver resections (hemi-hepatectomies and extended hemi-
hepatectomies) (21.5%) and patients with lesser resections
(32.0%). Our study did not define the pattern of liver recurrence;
however, previous studies have shown no statistical significance
between the rate of surgical margin recurrence and the resection
margin width.8
Our findings are very relevant as hepatic resection is considered
the only potential curative treatment option for colorectal liver
metastasis associated with long-term survival. The goal of hepatic
resection is to achieve a complete resection while leaving sufficient
remnant functioning liver in patients who are fit for surgery.
Recent advances in surgical technique, anaesthesia and oncology
have enabled more patients to undergo hepatic resection. This
study demonstrates that a histological margin of greater than
1 mm is associated with significantly better patient survival.
Although we aim to achieve a margin larger than 1 mm, and for
safety 10 mm where possible, it is appropriate to embark on
potentially curative resections in patients where at least a 1-mm
margin can be obtained.
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